Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing standing type 1 diabetes

被引:39
|
作者
Molitch, ME
Rupp, D
Carnethon, M
机构
[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.2337/diacare.29.01.06.dc05-1583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The objective of this study was to determine whether high levels of HDL cholesterol are associated with a lower prevalence of albuminuria. RESEARCH DESIGN AND METHODS - We analyzed the lipid profiles of patients with type I diabetes of >= 20 years duration in 42 patients With albuminuria (28 microalbuminuria and 14 macroalbuminuria) and 65 patients without increased albumin excretion before any interventions with either statins or ACE inhibitors. RESULTS - Several characteristics were similar in the two groups: sex, age, duration of diabetes, total cholesterol, LDL cholesterol, and triglycerides. By univariate analysis, significant differences (P < 0.01) were found in HDL cholesterol (albuminuria 1.42 mg/dl, no albuminuria 1.71 mg/dl, P < 0.01), HbA(1c) (AlC) (albuminuria 8.5%, no albuminuria 7.5%), and proportions with no, background, and proliferative retinopathy (albuminuria 2.4, 16.7, and 81%; no albuminuria 24.6, 52.3, and 23.1%, respectively). When adjusted for age and sex, a 0.26-mmol/l (10-mg/dl) increase in HDL cholesterol is associated with an odds ratio (OR) of 0.70 (95% CI 0.54-0.90) for having albuminuria. In a multivariate model that adjusted for age, sex, diabetes duration, and AlC, for every 0.54-mmol/l (21-mg/dl) increase in HDL cholesterol, patients are approximately half (OR 0.51 [95% CI 0.30-0.86]) as likely to have albuminuria, even after controlling or AlC. CONCLUSIONS - Higher HDL cholesterol levels may be protective against the development of albuminuria in patients with type I diabetes. Whether this is due to the HDL cholesterol levels or whether they serve as a marker for some other mechanism remains to be determined.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 50 条
  • [1] Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes - Response to Molitch et al.
    Wierusz-Wysocka, B
    Zozulinska, DA
    Araszkiewicz, A
    Pisarczyk-Wiza, D
    DIABETES CARE, 2006, 29 (05) : 1176 - 1177
  • [2] Higher levels of HDL cholesterol (HDL-C) are associated with a decreased likelihood of diabetic nephropathy (DN) in patients with long-standing type 1 diabetes
    Molitch, ME
    Rupp, D
    Carnethon, M
    DIABETES, 2005, 54 : A198 - A198
  • [3] EXOCRINE PANCREATIC AUTOANTIBODIES LEVELS HIGHER IN LONG-STANDING TYPE 1 DIABETES MELLITUS.
    Ragimov, M.
    Pekareva, E.
    Ibragimova, L.
    Derevyanko, O.
    Nikonova, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A243 - A243
  • [4] Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
    Gourgari, Evgenia A.
    Mete, Mihriye
    Sampson, Maureen L.
    Harlan, David M.
    Remaley, Alan T.
    Rother, Kristina I.
    DIABETES CARE, 2017, 40 (07) : E88 - E89
  • [5] Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
    Daniel Espes
    Joey Lau
    Per-Ola Carlsson
    Diabetologia, 2014, 57 : 50 - 53
  • [6] Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
    Espes, Daniel
    Lau, Joey
    Carlsson, Per-Ola
    DIABETOLOGIA, 2014, 57 (01) : 50 - 53
  • [7] Increased levels of irisin in people with long-standing Type1 diabetes
    Espes, D.
    Lau, J.
    Carlsson, P. O.
    DIABETIC MEDICINE, 2015, 32 (09) : 1172 - 1176
  • [8] Factors associated with resistance to complications in long-standing type 1 diabetes in China
    Liu, W.
    Wang, Y.
    Han, X.
    Cai, X.
    Zhu, Y.
    Zhang, M.
    Gong, S.
    Li, J.
    Ji, L.
    ENDOCRINE CONNECTIONS, 2020, 9 (02) : 187 - 193
  • [9] PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES
    Steenkamp, Devin W.
    Cacicedo, Jose M.
    Sahin-Efe, Ayse
    Sullivan, Catherine
    Sternthal, Elliot
    ENDOCRINE PRACTICE, 2017, 23 (12) : 1387 - 1393
  • [10] Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes
    Sewing, Lilian
    Potasso, Laura
    Baumann, Sandra
    Schenk, Denis
    Gazozcu, Furkan
    Lippuner, Kurt
    Kraenzlin, Marius
    Zysset, Philippe
    Meier, Christian
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (05) : 837 - 847